PHILADELPHIA — WWE’s “SmackDown” rolled into Xfinity Mobile Arena on Friday night, building directly on the fallout from SummerSlam 2026 with the returns of Kevin Owens and Randy Orton and a surprise NXT call-up that closed the show on a high note.

The episode was headlined by a long-anticipated singles showdown between Charlotte Flair and Jade Cargill, a match that had been building since Cargill’s arrival in WWE but had never materialized as a one-on-one contest until Friday’s broadcast, delivering what recap coverage described as an “absolute banger” despite some botched spots along the way.

A Chaotic Main Event Closes the Show

Flair and Cargill traded a physical, back-and-forth main event that saw Cargill hit a Black-Hole Slam, a sleeper hold and an avalanche Batista Bomb, while Flair countered with a Queen’s Boot, a German suplex and, most dramatically, a diving Natural Selection off the top rope. The match’s finish turned chaotic when Cargill’s allies, B-Fab and Michin, interfered to break up Flair’s Figure 8 submission attempt, prompting the returning Alexa Bliss to appear holding her signature Lilly doll before the arena lights cut out entirely.

When the lights returned, former NXT Champion Tatum Paxley had arrived, taking out both interfering competitors and clearing the way for Flair to hit a Sister’s Abigail DDT before finishing Cargill off. The debut immediately fueled speculation about a new alliance forming between Flair, Bliss and Paxley heading into the fall.

Punk and Rhodes Reignite Their Rivalry

The show’s opening segment picked up directly from SummerSlam, where CM Punk retained the Undisputed WWE Championship over Cody Rhodes after a surprise return from Randy Orton, who delivered an RKO to Rhodes before Punk finished him off with a Go To Sleep. On Friday, Rhodes opened “SmackDown” and pressed Punk on whether he had known in advance that Orton was returning to interfere in their SummerSlam match. Punk responded, “Say when,” setting the tone for a tense exchange that carried into Kevin Owens’ return later in the night.

Once Owens appeared, he directly confronted Punk over his continued arrogance, telling him, “You’re out here proving me right,” and later adding, “If it wasn’t for me you wouldn’t even be here right now.” Tension between the two nearly boiled over when Owens shoved Punk, prompting WWE SmackDown General Manager Nick Aldis to look on nervously from ringside. According to recap coverage, Owens has requested that his match against Punk take place on the Aug. 21 edition of “SmackDown” in Toronto.

Orton and Rhodes Finally Face Off

Later in the show, Orton made his first “SmackDown” entrance since WrestleMania, prompting an immediate confrontation with Rhodes. Orton explained that he had specifically asked to face the best version of Rhodes, but that in pushing him toward that peak, he had also drawn out Rhodes’ worst instincts. Rhodes fired back, telling Orton that with the WWE Championship no longer around his waist, he had no reason left to continue playing the role of a “good guy.” The heated exchange strongly suggested a program between the two former allies is being set up for the coming weeks.

Championship Storylines Continue to Develop

Elsewhere on the card, Baron Corbin retained the United States Championship against Trick Williams, while the Women’s Tag Team Championship saw Fatal Influence, made up of Lainey Reid and Fallon Henley, retain their titles in a match against new Women’s World Champion Chelsea Green and Tiffany Stratton. Notably, Green ate the pin in the loss during just her first match since winning the title, a booking decision that recap coverage suggested reflected poorly on how WWE has positioned the new champion so far. Green’s title win came after Rhea Ripley underwent knee surgery this week, forcing a change at the top of the women’s division; WWE has notably listed Green simply as champion without any interim designation on her official profile.

Green and Stratton are now set to face off for the U.S. Women’s Championship the following week, continuing a storyline that has also involved Jacy Jayne, who appeared in a managerial role during the segment rather than as an active competitor.

Other Notable Moments

Friday’s broadcast also featured a vignette from Shinsuke Nakamura, who remains locked in an ongoing feud with The Tongans, teasing that he would return with additional support rather than facing the group alone. Separately, Nikki Bella addressed her recent heel turn against Paige, framing her actions as part of a deliberate mission to make Paige’s life difficult going forward. Sami Zayn also factored into the night’s storytelling, interacting with both Owens and Punk at various points, fueling speculation that he could eventually reinsert himself into their developing rivalry. Notably, Gunther, who has recently moved from WWE’s Raw brand over to SmackDown, was absent from Friday’s card entirely, a choice recap coverage attributed to deliberate misdirection around his character rather than any behind-the-scenes issue.

Full Card Results

Charlotte Flair defeated Jade Cargill in the show’s main event. In the Women’s Tag Team Championship match, Fatal Influence, Lainey Reid and Fallon Henley, defeated challengers Tiffany Stratton and Chelsea Green to retain their titles. In the United States Championship match, Baron Corbin defeated Trick Williams to retain the title.

With Owens and Punk now set to collide in Toronto on Aug. 21, and the Orton-Rhodes rivalry appearing to be building toward a more concrete program, WWE’s “SmackDown” brand appears to be entering an extended stretch of storyline payoff following SummerSlam. Meanwhile, the debut of Tatum Paxley alongside the returning Alexa Bliss and established star Charlotte Flair opens a new storyline thread on the women’s side of the roster, one that fans and analysts will be watching closely in the coming weeks to see whether WWE fully capitalizes on the trio’s on-screen chemistry.

Ageing has always been measured in visible terms — grey hair, slower recovery after a workout, a knee that complains on cold mornings. But underneath those visible markers, researchers increasingly believe a much smaller story is playing out: a decline in a single molecule found in every cell of the human body, called NAD+.

Nicotinamide adenine dinucleotide, or NAD+, isn’t a hormone, a vitamin, or a drug. It’s a coenzyme — a helper molecule that almost every cell needs to convert food into usable energy. Without it, the biochemical machinery that keeps mitochondria running would simply stop. And according to a growing body of research, our supply of it doesn’t stay constant over a lifetime. It falls.

A Battery That Runs Down With Age

Think of NAD+ less like a nutrient you stock up on and more like a rechargeable battery your cells draw from constantly. Every time a cell needs energy, repairs damaged DNA, or manages inflammation, it dips into that NAD+ supply.

The trouble is, the demand goes up as the supply goes down. Studies looking at human tissue samples have found NAD+ levels can fall by roughly a third to a half between early adulthood and one’s fifties and sixties. At the same time, the enzymes competing for that shrinking pool — including sirtuins, which help regulate metabolism and cellular repair, and PARPs, which fix damaged DNA — become busier, not less busy, as we accumulate everyday wear and tear.

Researchers studying this dynamic have described mitochondria as acting like internal “reservoirs” that store NAD+ for cells to draw on. When those reservoirs run low over an extended period, cells can struggle to power the processes that keep tissue and organs functioning well. That combination — rising demand, falling supply — is one reason NAD+ has moved from a biochemistry footnote to a genuine focus of ageing research.

Why This Matters Beyond the Lab

It’s worth being honest about where the science currently stands. Much of the strongest evidence for NAD+’s role in ageing comes from animal studies and cellular models, and human research is still catching up. That said, the mechanistic case is compelling enough that it’s now a serious area of study at major research institutions, and it helps explain patterns most people notice anecdotally as they get older:

• Recovery from exercise or illness that takes noticeably longer than it used to
• A general sense of reduced stamina, even without any specific illness
• Slower wound healing and skin repair
• A “foggier” baseline of mental sharpness on ordinary days

None of these symptoms map perfectly onto NAD+ alone — ageing is never explained by a single molecule. But the underlying biology gives a plausible, well-documented mechanism for why cellular energy production becomes less efficient with time, and why that inefficiency shows up as the everyday experience of “getting older.”

What the Research Community Is Exploring

Because NAD+ itself is broken down quickly if taken directly, most research and product development has focused on precursors — molecules like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) that the body can convert into NAD+ — as well as direct NAD+ delivery methods such as intravenous or subcutaneous administration, which bypass some of the absorption challenges of oral precursors.

Early human trials of these precursors have shown they can meaningfully raise NAD+ levels in the blood within a matter of weeks. What’s less settled is how reliably that translates into the long list of benefits often claimed in marketing copy — better sleep, sharper cognition, improved metabolic health. Some of these outcomes have supportive early data; others remain plausible extrapolations from cellular biology rather than proven clinical results. Anyone considering this category should treat it the way they would any emerging area of medicine: worth watching closely, not yet a settled science.

Turning the Science Into Something Practical

For most people, the most evidence-backed way to support NAD+ levels doesn’t come in a vial at all. Regular exercise, adequate sleep, time-restricted eating patterns, and limiting excessive alcohol intake have all been linked to healthier NAD+ metabolism through their effects on mitochondrial function and the enzymes that regulate it. These are the same habits that show up in virtually every longevity study, for reasons that increasingly trace back to this same cellular pathway.

Beyond lifestyle, a growing number of people are turning to diagnostic testing to get an actual read on their biological markers rather than guessing. Companies operating in this space — NADdirect among them — now offer both precursor-based supplements and testing services aimed at helping people understand where they stand before deciding whether supplementation makes sense for them.

If you’re curious about your own NAD+-related biology, the most useful first step isn’t necessarily a purchase — it’s a conversation with a doctor about what testing or intervention, if any, actually fits your health picture. Ageing well has always been about the boring fundamentals: sleep, movement, food, and stress management. NAD+ research doesn’t replace that advice. It just explains, in increasingly precise detail, why it’s always been true.